| Year |
Author |
Title |
| 2020 |
Luinstra, M. |
Inhalable levodopa: from laboratory to the patient
|
| 2019 |
Bigaeva, E. |
Ex vivo fibrosis research: 5 mm closer to human studies
|
| 2019 |
Gore, E. |
Integrating an ex vivo model into fibrosis research
|
| 2019 |
Iswandana, R. |
Exploring the regional characteristics of intestinal drug metabolism and fibrogenesis
|
| 2019 |
Putri, K.S.S. |
Osteoprotegerin in organ fibrosis: biomarker, actor, and target of therapy?
|
| 2019 |
Ruigrok, M.J.R. |
siRNA in precision-cut lung slices: knocking down fibrosis?
|
| 2019 |
Suriguga, S. |
Pro- and anti-fibrotic agents in liver fibrosis: perspective from an ex vivo model of liver fibrosis
|
| 2018 |
Bhide, Y. |
Towards improved and broadly protective influenza vaccines: focus on delivery systems, routes of administration and animal models
|
| 2018 |
Kanojia, G. |
Drying made easy: spray drying a promising technology for the production of stable vaccine and therapeutic protein formulations
|
| 2018 |
Teekamp, N. |
Protein delivery from polymeric matrices: from pre-formulation stabilization studies to site-specific delivery
|
| 2018 |
Tomar, J. |
Paving the way for pulmonary influenza vaccines: exploring formulations, models and site of deposition
|
| 2017 |
Luangmonkong, T. |
Exploring anti-fibrotic drugs: focusing on an ex vivo model of fibrosis
|
| 2017 |
Mensink, M. |
Solid state stabilization of proteins by sugars: why size and flexibility matter
|
| 2017 |
Stribos, E.G.D. |
Ex vivo studies of renal fibrosis: insights into mechanisms and treatment targets
|
| 2017 |
Visser, J.C. |
Orodispersible films as pharmacy preparations: let’s get flexible
|
| 2016 |
Grasmeijer, N. |
Improving protein stabilization by spray drying: formulation and process development
|
| 2016 |
Hoppentocht, M. |
Dry powder inhalation of antibiotics: a promising approach for treatment of infectious diseases
|
| 2016 |
Pham, B.T. |
Precision-cut tissue slices: a novel ex vivo model for fibrosis research
|
| 2014 |
Grasmeijer, F. |
Adhesive mixtures for inhalation: the cohesion between formulation variables, inhalation variables and dispersion performance
|
| 2014 |
Lexmond, A. |
Technology in practice: the importance of matching purpose, patient, and product in pulmonary aerosol delivery
|
| 2014 |
Murugappan, S. |
New strategies for simplifying influenza vaccination
|
| 2014 |
Nguyen, T. |
Particle–particle interactions in dry powder blending: applying theoretical concepts to real-life particles
|
| 2014 |
Stankovic, M. |
Innovative platform technologies for stabilization and controlled release of proteins from polymer depots
|
| 2014 |
Tonnis, W. |
Powder to the people: the storage stability, handling, and administration advantages of powder formulations for pulmonary vaccination
|
| 2013 |
Willemsz, T.A. |
Blending of agglomerates into powders: quantification and understanding of mixing mechanisms in dry blending
|
| 2012 |
Avanti, C. |
Innovative strategies for stabilization of therapeutic peptides in aqueous formulations
|
| 2011 |
de Waard, H. |
A novel bottom-up process to prepare drug nanocrystals: the art of the soluble
|
| 2011 |
Schellekens, R.C.A. |
Translational research into oral colon-specific drug delivery: from laboratory to clinic
|
| 2011 |
Srinarong, P. |
Improved dissolution behavior of lipophilic drugs by solid dispersions: a matter of composition
|
| 2010 |
Laksmana, F.L. |
Functional encapsulation of small particles: quantification and control of the morphology of the coating layers
|
| 2010 |
Saluja, V. |
Novel perspectives for influenza vaccine formulation and administration: L. lactis cell wall derived adjuvant, stable dry powder vaccines and mucosal vaccine delivery
|
| 2009 |
Westerman, E.M. |
Studies on antibiotic aerosols for inhalation in cystic fibrosis
|
| 2009 |
Zijlstra, G.S. |
Dry powder inhalation of biopharmaceuticals: from formulation to proof-of-concept
|
| 2008 |
Amorij, J-P. |
The development of stable influenza vaccine powder formulations for new needle-free dosage forms
|
| 2008 |
Wu, Y.S. |
Looking into tablets: characterization of pore structure in tablets using image analysis
|
| 2007 |
de Jonge, J.M. |
Reconstituted viral envelopes as delivery vehicles for nucleic acids
|
| 2007 |
de Vegt, O.M. |
Jet milling from a particle perspective: predicting particle fracture based on mechanical material properties
|
| 2007 |
Weda, M. |
Equivalence testing of inhaled drugs: the predictive value of cascade impactor results for the detection of differences in efficiency and safety of medicines for the treatment of asthma and COPD
|
| 2006 |
Dickhoff, B.H.J. |
Adhesive mixtures for powder inhalation: the effect of carrier (surface and bulk) properties, carrier payload and mixing conditions on the performance of adhesive mixtures for inhalation
|
| 2006 |
van Drooge, D.J. |
Combining the incompatible: inulin glass dispersions for fast dissolution, stabilization and formulation of lipophilic drugs
|
| 2005 |
Bouwman, A.M. |
Form, formation and deformation: the influence of material properties and process conditions on the shape of granules produced by high shear granulation
|
| 2005 |
de Boer, A.H. |
Optimisation of dry powder inhalation: the application of air classifier and laser diffraction technology for the generation and characterisation of aerosols from adhesive mixtures
|
| 2005 |
Steendam, R. |
Amylodextrin and poly(DL-lactide) oral controlled release matrix tablets: concepts for understanding their release mechanisms
|
| 2004 |
Eriksson, H.J.C. |
Analytical techniques and formulation strategies for the therapeutic protein alkaline phosphatase
|
| 2003 |
van Veen, B. |
Compaction of powder blends : effect of pores, particles and percolation on tablet strength
|
| 2002 |
van Sorge, A.A. |
Reflections on flurbiprofen eyedrops
|
| 2001 |
de Koning, J.P. |
Dry powder inhalation: technical and physiological aspects, prescribing and use
|
| 2001 |
Le Brun, P.P.H. |
Optimization of antibiotic inhalation therapy in cystic fibrosis: studies on nebulized tobramycin
|
| 2001 |
Ramaker, J.S. |
Fundamentals of the high-shear pelletisation process
|
| 2000 |
Hartman Kok, P.J.A. |
Development and description of controlled release formulations for use in powder detergents
|
| 2000 |
Schaafsma, S.H. |
Down-scaling of a fluidised bed agglomeration process
|
| 2000 |
Wientjes, K.J.C. |
Development of a glucose sensor for diabetic patients
|
